Taurine modulates catalytic activity of cytochrome P450 3A4

被引:0
|
作者
V. V. Shumyantseva
A. A. Makhova
T. V. Bulko
R. Bernhardt
A. V. Kuzikov
E. V. Shich
V. G. Kukes
A. I. Archakov
机构
[1] Orekhovich Institute of Biomedical Chemistry,Institute for Biochemistry
[2] Sechenov First Moscow State Medical University,undefined
[3] Saarland University,undefined
来源
Biochemistry (Moscow) | 2015年 / 80卷
关键词
cytochrome P450; antioxidants; drug metabolism; bioelectrochemistry; taurine;
D O I
暂无
中图分类号
学科分类号
摘要
The influence of the biologically active compound taurine on the stability and catalytic properties of the hemoprotein cytochrome P450 3A4 has been investigated. The catalytic properties were analyzed by electrochemical methods (cyclic and square-wave voltammetry) using cytochrome P450 3A4 immobilized on the electrode. Taurine at concentrations in the range 10–70 μM stimulated the electrochemical reduction of cytochrome P450 3A4, and the reduction was the highest (115 ± 3%) in the presence of 50 μM taurine. Taurine pronouncedly attenuated the itraconazol-caused inhibition of the P450 isoenzyme P450 3A4. Taurine protected cytochrome P450 3A4 due to stabilizing it during electrolysis at controlled voltage in the presence of erythromycin as a substrate. This protection was manifested by an increase in the amount of the “residual” reduced form of the hemoprotein (52 ± 5 and 71 ± 8%, respectively).
引用
收藏
页码:366 / 373
页数:7
相关论文
共 50 条
  • [21] Cooperativity in oxidations catalyzed by cytochrome P450 3A4
    Ueng, YF
    Kuwabara, T
    Chun, YJ
    Guengerich, FP
    BIOCHEMISTRY, 1997, 36 (02) : 370 - 381
  • [23] Lack of electron transfer from cytochrome b(5) in stimulation of catalytic activities of cytochrome P450 3A4 - Characterization of a reconstituted cytochrome P450 3A4 NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b(5)
    Yamazaki, H
    Johnson, WW
    Ueng, YF
    Shimada, T
    Guengerich, FP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) : 27438 - 27444
  • [24] Cytochrome P450 3A4 activity in two ethnic groups in Malaysia.
    Mohamed, Z
    Mustafa, AM
    Jamal, SK
    Mustafa, MR
    Jeyalingam, K
    Lang, CC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 221 - 221
  • [25] Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe
    Majumdar, AK
    McCrea, JB
    Panebianco, DL
    Hesney, M
    Dru, J
    Constanzer, M
    Goldberg, MR
    Murphy, G
    Gottesdiener, KM
    Lines, CR
    Petty, KJ
    Blum, RA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (02) : 150 - 156
  • [26] Docking Study of Noscapine into the Activity Cavity of Cytochrome P450 (CYP) 3A4
    Liu, Wenhua
    Wang, Shaofeng
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (05): : 875 - 878
  • [27] Altered hepatic cytochrome P450 3A4 activity following surgical stress
    Kaufman, DC
    Haas, C
    Jones, CE
    Reiss, W
    Burstein, A
    Shaw-Stiffel, TA
    Shortell, C
    Illig, K
    CRITICAL CARE MEDICINE, 1999, 27 (12) : A145 - A145
  • [28] Substrate dependent effect of dimethyl sulfoxide on cytochrome P450 3A4 activity
    Day, SH
    Benini, R
    Nicoll-Griffith, D
    Chauret, N
    Silva, JM
    FASEB JOURNAL, 2000, 14 (08): : A1337 - A1337
  • [29] Influence of cytochrome P450 3A4 and membrane lipid composition on doxorubicin activity
    dos Santos, Kevin F.
    Materon, Elsa M.
    Oliveira Jr, Osvaldo N.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2022, 220
  • [30] Inhibition of human cytochrome P450 3A4 activity by zinc(II) ion
    Kim, JS
    Yun, CH
    TOXICOLOGY LETTERS, 2005, 156 (03) : 341 - 350